Role of IgE in hyperresponsiveness induced by passive sensitization of human airways

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 3, 1997, Pages 839-844

  Watson, Nikki ^b   Bodtke, Kristina ^b   Coleman, Robert A ^b   Dent, Gordon ^b   Morton, Benita E ^b   Rühlmann, Elke ^b   Magnussen, Helgo ^b   Rabe, Klaus F ^a  

^a KRANKENHAUS GROSSHANSDORF   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; HISTAMINE; IMMUNOGLOBULIN E;

ADULT; AGED; ARTICLE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; BRONCHUS REACTIVITY; CLINICAL ARTICLE; FEMALE; HISTAMINE RELEASE; HUMAN; MALE; PRIORITY JOURNAL; SENSITIZATION;

EID: 0030893860     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.3.9117014     Document Type: Article

References (22)

1. Dunlop, L. S., and A. P. Smith. 1975. Reduction of antigen-induced contraction of sensitized human bronchus in vitro by indomethacin. Br. J. Pharmacol. 54:459-497.
2. Davis, C., T. R. Jones, and E. E. Daniel. 1982. Studies of the mechanism of passive anaphylaxis in human airway smooth muscle. Can. J. Physiol. 61:705-713.
3. Creese, B. R., and D. M. Temple. 1986. The mediators of allergic contraction of human airway smooth muscle: a comparison of bronchial and lung parenchymal strip preparations. Clin. Exp. Pharmacol. Physiol. 13:103-111.
4. Roberts, J. A., and N. C. Thomson. 1989. The effect of passive sensitization of human bronchial smooth muscle on in vitro sensitivity to histamine. PuIm. Pharmacol. 2:103-105.
5. Black, J. L., R. Marathon, C. L. Armour, and P. R. A. Johnson. 1989. Sensitization alters contractile responses and calcium influx in human airway smooth muscle. J. Allergy Clin. Immunol. 84:440-447.
6. Björck, T., Y. Harada, B. Dahlén, O. Zetterström, G. Johansson, L. Rodriguez, P. Heqvist, and S. E. Dahlén. 1990. Further evidence that leukotrienes are the major mediators of allergic bronchoconstriction in human bronchi. Adv. Prostaglandin Thromboxane Leukot. Res. 21:429-432.
7. Tunon de Lara, J. M., Y. Okayama, J.-P. Savineau, and R. Marthan. 1995. 1gE-induced passive sensitization of human isolated bronchi and lung mast cells. Eur. Respir. J. 8:1861-1865.
8. Marthan, R., H. Crevel, H. Guénard, and J.-P. Savineau. 1992. Responsiveness to histamine of human sensitized airway smooth muscle. Respir. Physiol. 90:1706-1714.
9. Ben-Jebria, A., R. Marthan, M. Rossetti, and J.-P. Savineau. 1993. Effect of passive sensitization on the mechanical activity of human isolated bronchial smooth muscle induced by substance P, neurokinin A and VIP. Br. J. Pharmacol. 109:131-136.
10. Schild, H. O., D. F. Hawkins, J. L. Mongar, and H. Herxheimer. 1951. Reactions of isolated human asthmatic lung and bronchial tissue to a specific antigen: histamine release and muscular contraction. Lancet i:376-382.
11. Yamaguchi, T., H. Kohrogi, I. Honda, O. Kawano, M. Sugimoto, S. Araki, and M. Ando. 1992. A novel leukotriene antagonist, ONO-1079, inhibits and reverses human bronchial contraction induced by leukotrienes C4 and D4 and antigen in vitro. Am. Rev. Respir. Dis. 146:923-929.
12. Malo, P. E., R. L. Bell, T. K. Shaughnessy, J. B. Summers, D. W. Brooks, and G. W. Carter. 1994. The 5-lipoxygenase inhibitory activity of zileuton in in vitro and in vivo models of antigen-induced airway anaphylaxis. PuIm. Pharmacol. 7:73-79.
13. Mitchell, R. W., E. Rühlmann, H. Magnussen, A. R. Leff, and K. F. Rabe. 1994. Passive sensitization of human bronchi augments smooth muscle shortening velocity and capacity. Am. J. Physiol. 267 (Lung Celt. Mol. Physiol. 11):L218-L222.
14. Rossetti, M., J.-P. Savineau, C. Huguette, and R. Marthan. 1995. Role of protein kinase C in nonsensitized and passively sensitized human isolated bronchial smooth muscle. Am. J. Physiol. 268 (Lung Cell. Mol. Biol. 12):L966-L971.
15. Burrows, B., F. D. Martinez, M. Halonen, R. A. Barbee, and M. G. Cline. 1989. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N. Engl. J. Med. 230:271-277.
16. Pride, N. B., R. G. Taylor, T. K. Lim, H. Joyce, and A. Watson. 1987. Bronchial hyperresponsiveness as a risk factor for progressive airflow obstruction in smokers. Bull. Eur. Physiopathol. Respir. 23:369-375.
17. Empey, D. W., L. A. Laitinen, L. Jacobs, W. M. Gold, and J. A. Nadel. 1976. Mechanism of bronchial hyperre inhibitory activity in normal subjects after upper respiratory tract infection. Am. Rev. Respir. Dis. 113:131-139.
18. Mullen, J. B., B. R. Wiggs, J. L. Wright, J. C. Hogg, and P. D. Paré. 1986. Non-specific airway reactivity in cigarette smokers: relationship to airway pathology and baseline lung function. Am. Rev. Respir. Dis. 133:120-125.
19. Neuberger, M. S., G. T. Williams, E. B. Michell, S. S. Jouhal, J. G. Flanagan, and T. H. Rabbitts. 1985. A hapten-specific chimaeric IgE antibody with human physiological effector function. Nature 314: 268-270.
20. Malveaux, F. J., M. C. Conroy, N. F. Adkinson, and L. M. Lichtenstein. 1978. IgE receptors on basophils: relationship to serum IgE concentrations. J. Clin. Invest. 62:176-181.
21. Metzger, H. 1992. The receptor with high affinity for IgE. Immunol. Rev. 125:37-48.
22. Sutton, B. J., and H. J. Gould. 1993. The human IgE network. Nature 366:421-428.